| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/30/1993 | EP0548245A1 Metal-radionuclide complex comprising isonitrile ligands |
| 06/30/1993 | CN1073680A Synthesis of polyazamacrocycles with more than one type of side-chain groups |
| 06/29/1993 | US5223482 Polypeptide |
| 06/29/1993 | US5223242 In situ imaging or therapy method |
| 06/29/1993 | US5223241 Administering detection of labeled immunoglobin which accumulates at site; directed against MHC antigens |
| 06/24/1993 | WO1993012231A1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 06/24/1993 | WO1993012097A1 Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups |
| 06/24/1993 | WO1993011802A1 Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation |
| 06/24/1993 | WO1993011801A1 Bicyclopolyazamacrocyclophosphonic acid complexes, their preparation, conjugates and radiopharmaceuticals |
| 06/24/1993 | WO1993011800A1 Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents |
| 06/24/1993 | WO1993011796A1 Further improvements relating to the radiolabelling of proteins |
| 06/24/1993 | WO1993011771A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
| 06/24/1993 | CA2125975A1 Further improvements relating to the radiolabelling of proteins |
| 06/24/1993 | CA2125773A1 Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups |
| 06/24/1993 | CA2125404A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
| 06/24/1993 | CA2103555A1 Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals |
| 06/23/1993 | EP0272278B1 $i(D)-GL CONJUGATE THERAPY |
| 06/23/1993 | EP0247156B1 Polychelating agents for image and spectral enhancement (and spectral shift) |
| 06/15/1993 | US5220013 Use of materials related to amyloid protein deposits |
| 06/15/1993 | US5219556 Lyophilizing an aqueous solution of a complex of an alpha or beta ray-emitting radionuclide and a ligand; reconstituting "on site" by adding a diluent |
| 06/15/1993 | US5219555 Method for labeling proteins with technetium or rhenium |
| 06/15/1993 | US5219548 Used for selectively binding estrogen receptors of a tissue |
| 06/11/1993 | WO1993012112A1 Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates processes for their preparation, and use as radiopharmaceuticals |
| 06/11/1993 | CA2103553A1 Bicyclopolyazamacrocyclocarboxylic acid complexes their conjugates, processes for their preparation, and use as radiopharmaceuticals |
| 06/10/1993 | WO1993011120A1 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 06/10/1993 | WO1993010823A1 Nitrogen-sulfur ligands as opiate receptor mimics |
| 06/10/1993 | WO1993010822A1 TECHNETIUM-99 m COMPLEXES WITH N-SUBSTITUTED 3-HYDROXY-4-PYRIDINONES |
| 06/10/1993 | WO1993010747A2 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 06/10/1993 | WO1993010743A2 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 06/10/1993 | CA2125025A1 Technetium-99m complexes with n-substituted 3-hydroxy-4-pyridinones |
| 06/10/1993 | CA2124560A1 Nitrogen-sulfur ligands as opiate receptor mimics |
| 06/09/1993 | EP0544878A1 Asialoglycoprotein-conjugated medicinal agent |
| 06/08/1993 | US5218128 Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom |
| 06/08/1993 | US5217705 Method of diagnosing blood clots using fibrin-binding proteins |
| 06/08/1993 | US5217704 Methods and materials for the preparation of metal labelled antibody solutions |
| 06/02/1993 | EP0544412A2 Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 06/02/1993 | EP0422090B1 Derivatives of nucleosides which may be used for the synthesis of marked oligonucleotides, and oligonucleotides obtained from these derivatives and their synthesis |
| 06/02/1993 | EP0369000A4 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 06/01/1993 | US5216130 Coupling polysaccharide spacer arm to central albumin core of complex; radioactive labels |
| 06/01/1993 | CA1318668C Radioiodine benzodiazepine derivatives |
| 06/01/1993 | CA1318615C Radiohalogenated compounds for site specific labeling |
| 06/01/1993 | CA1318614C Single vial technique for radio-labeling protein |
| 05/27/1993 | WO1993009816A1 Method for diagnosing and treating cancer |
| 05/27/1993 | WO1993009814A1 Cocaine receptor binding ligands |
| 05/27/1993 | WO1993009813A1 Therapeutic compounds |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2123588A1 Method for diagnosing and treating cancer |
| 05/26/1993 | EP0543482A1 Aminocarboxylate ligands having substituted aromatic amide moieties |
| 05/26/1993 | EP0420880B1 A method for the visual display of tumors using monoclonal antibodies |
| 05/19/1993 | EP0542216A1 Diaminomercapto (thio)ethers as complexing agents for nucleides applicable in nuclear medicine, process for the preparation of this complexes, and masking kits containing them |
| 05/19/1993 | EP0541719A1 New carbohydrate-based anti-inflammatory agents |
| 05/19/1993 | EP0541543A1 Soluble irradiation targets and methods for the production of radiorhenium |
| 05/19/1993 | EP0426759B1 Novel tc-99m complexes |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212085 Monoclonal antibodies |
| 05/18/1993 | US5211937 Method of determining a site of inflammation utilizing elam-1 ligands |
| 05/18/1993 | US5211936 Endothelial leukocyte adhesion molecule |
| 05/18/1993 | CA1317937C Gadolinium chelates with carboxymethyl derivatives of polyazamacrocycles as nmr contrast agents |
| 05/13/1993 | WO1993008846A1 Contrast media |
| 05/13/1993 | WO1993008839A1 Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents |
| 05/13/1993 | WO1993008813A1 Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis |
| 05/13/1993 | CA2122726A1 Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents |
| 05/12/1993 | EP0540975A1 Diethylenetriamine derivatives and their use for diagnostic and therapeutic purposes |
| 05/12/1993 | EP0540858A1 Inflatable member having elastic expansion with limited range |
| 05/12/1993 | CN1071928A Rhenium and technetium complexes containing hypoxia-localizing moiety |
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/11/1993 | US5209919 Method of measurement in biological systems |
| 05/11/1993 | CA1317544C Method for labeling antibodies with a metal ion |
| 05/07/1993 | CA2082023A1 Diethylenetriamine derivatives and their use for diagnostic and therapeutic purposes |
| 05/04/1993 | US5208324 Paramagnetic compounds |
| 05/04/1993 | US5208007 Isotopic tracer composition and method for making and using same |
| 04/29/1993 | WO1993008210A1 Vascular permeability factor targeted compounds |
| 04/29/1993 | WO1993007875A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | CA2121838A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/28/1993 | EP0539165A1 Inter-biliary duct stent |
| 04/28/1993 | EP0538402A1 Method of preparing a radioactive rhenium complex solution |
| 04/28/1993 | EP0386146B1 Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy |
| 04/27/1993 | US5206007 Useful in image diagnosis of heart diseases |
| 04/27/1993 | US5205290 Kits for imaging gastrointestinal disorders; anti-gas; biocompatible polymers, thickeners |
| 04/22/1993 | CA2080876A1 Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct |
| 04/15/1993 | WO1993006858A1 Lung cancer-associated protein |
| 04/15/1993 | CA2120363A1 Lung cancer-associated protein |
| 04/13/1993 | US5202451 Anchimeric radiometal chelating compounds |
| 04/13/1993 | US5202109 Conjugates for bone imaging and bone cancer therapy |
| 04/13/1993 | CA1316296C Technetium chelates to be used for determining the renal function |
| 04/08/1993 | DE4132925A1 Medical plaster - incorporates lead@ layer for absorbing gamma-or X=ray radiation to protect ambience of patient undergoing radioisotope therapy |
| 04/07/1993 | EP0535668A1 Imaging agent for diagnosis |
| 04/06/1993 | US5200178 Method for tumor detection |
| 04/06/1993 | US5200169 Benzoic acid is boned between vinyl halide and activated functional group for bonding to monoclonal antibodies; stability, medical diagnosis |
| 04/01/1993 | WO1993006148A1 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications |
| 04/01/1993 | WO1993006132A1 Modified peptide derivatives |
| 04/01/1993 | WO1993005658A1 Targeted cytotoxic effector cells and methods for their production and use |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | CA2118595A1 Modified peptide derivatives |
| 04/01/1993 | CA2116357A1 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications |
| 03/31/1993 | EP0533845A1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER |
| 03/30/1993 | US5198460 Pyropheophorbides and their use in photodynamic therapy |
| 03/30/1993 | US5198208 Aminopolycarboxylic acids and derivatives thereof |
| 03/26/1993 | CA2077309A1 Polymeric carriers for release of covalently linked agents |